Minimize Cost, Maintain Quality and Safety in Bioprocessing

Bioprocessing with Octet®️ Bio-Layer Interferometry

To accelerate commercialization of biotherapeutics, organizations need to optimize processes by integrating advanced analytical tools that maximize quality, safety, and efficacy.

Octet® BLI systems enable real-time, label-free analysis for the determination of kinetics, affinity, and antibody/protein quantitation. Based on Bio-Layer Interferometry (BLI), the systems enable an enviable variety of applications throughout biologics development, from early selection to validation and manufacturing.

Read on to learn about the implementation in the production of biotherapeutics for titer, host cell protein analysis, residual protein detection, sialic acid content detection, potency assay development, Fab activity assay development, and more.

Find Out How You Can Leverage the Power of Octet®️

Boost your research and commercialization goals by combining BLI and SPR at an attractive promotional price. 

Explore Promotion

Bioprocessing Applications

Rapid, Automated, at-line AAV2 Virus Quantitation Advances Bioprocessing in Gene Therapy

Recombinant adeno-associated virus (rAAV) is one of the most promising viral vectors in gene therapy for genetic disorders. The highly versatile Octet® BLI platform can be used to design multiple AAV serotype-specific titer assays, as well as a generic assay method for viral titer at-line in a bioprocess setting. We outline the steps and materials needed to establish a fast, high-throughput, and robust AAV2 capsid quantification assay workflow that demonstrates excellent precision and reliability in comparison to ELISA and ddPCR.

Read Application Note

Validated Quantitation and Activity Assay of Antibody Fragment Molecule (Fab) for Process Development

The analytical group at Boehringer Ingelheim, Fremont, USA needed a robust assay to measure the biological activity of an antibody fragment (Fab) molecule for in-process testing as well as stability and lot release testing in their Quality Control (QC) department. The developed Fab activity assay is accurate and robust, with intermediate and intramediate precision less than 10%. Drug activity measurement using the Octet® BLI system has become a critical parameter for their product evaluation and has resulted in increased Fab drug product consistency and quality.

Read Application Note

Downstream Biologics Characterization: Stability, Formulations and Aggregation Studies

The formation of aggregates can affect the efficacy and safety of biologics. While many biophysical analytical tools can detect aggregates, few offer a combination of structural and functional assessment. The Octet® BLI platform can detect aggregates while monitoring functional activity at the formulation stage of drug development.

Read Application Guide

Enhanced Productivity and Labor Efficiency in Lot Release and In-Process Testing of Biologics

Octet® BLI instruments can be equipped with 21 CFR Part 11 Software for compliance with regulatory requirements. Compliance is further enhanced with the availability of instrument qualification kits including IQ|OQ and PQ kits that ensure the platform performs as stipulated. This white paper includes a few examples to demonstrate the suitability of BLI technology under GxP compliance for different applications and shows the relative benefits over alternate technologies.

Read White Paper

CHO Host Cell Protein Detection

Host Cell Proteins (HCPs) in finished products can decrease the efficacy of the drug or cause adverse immunogenic reactions.  Partnering with Cygnus Technologies, the Anti-CHO HCP Detection Kit for quantitation of residual HCPs brings the Octet® BLI systems high throughput analysis together with the broad HCP recognition and sensitivity of the leading Cygnus 3G anti-CHO HCP antibody.

Read Application Note

A Rapid Method to Quantitatively Screen Bispecific Antibody using Protein A and His1K Biosensors Bispecific

Scientists at Celgene Corporation developed a screening process incorporating the Octet® BLI platform. This allows them to identify pools and clones with higher concentrations of bispecific antibodies. High throughput was achieved from the multiple simultaneous measures possible on one system and rapid assays times, such as binding optimization in only 10 minutes.

Read Application Note

Modernize Biopharmaceutical QC Testing to Increase Efficiency

Up to 2x faster and with the ability to process 40x more samples per day, Octet® BLI systems are an ideal replacement for ELISA, HPLC or other label-free techniques for the quantification of antibodies and recombinant proteins and is especially suitable for product potency lot release assays. Boehringer Ingelheim were able to develop an active Fab quantitation assay for in-process testing as well as stability and lot release testing in less than one week using the Octet® BLI platform.

Read Application Guide

Mab Quantitation: Protein A HPLC vs. Protein A Bio-Layer Interferometry

Rapid, accurate and cost-effective quantitation of monoclonal antibodies (MAbs) is essential for bioprocessing. Here we assess the relative merits of Protein A High-Pressure Liquid Chromatography (HPLC) and Protein A bio-layer interferometry BLI using an eight-channel Octet® R8 systems to determine mAb concentration in a complex feedstock.

Read Application Note

Enhancing Efficiency and Economics in Process Development and Manufacturing of Biotherapeutics

The high cost and lengthy times associated with drug discovery and development have forced biopharm companies to improve the efficiency and economics. Biopharmaceutical companies have enthusiastically adopted Octet® BLI systems due to their broad utility in protein quantitation and functional characterization combined with enhanced throughput, decreased sample preparation requirements, and low cost of operation.

Read Application Note

Potency Assays: Development, Qualification and Validation Strategies

This app note discusses the strategies for the development and validation of a potency assay using BLI technology. The ease-of-use and fast time to results is highlighted by showcasing a method for evaluating the binding of an Fc gamma receptor III (FcγR) molecule to the widely characterized NIST mAb.

Read Application Note

Why Do Researchers Choose Genuine Octet® BLI?

Thousands of researchers trust Octet® BLI systems for superior
performance, confident compliance, and exceptional customer
service & support.

  • 7000+ Octet® BLI publications
  • 3,500+ instrument installs worldwide
  • Much, much more

See Why Researchers Choose Octet® BLI

Featured Resources

Application Note

Protein Domain Mapping Chemokines & SARS-CoV-2 Nucleocapsid

This application note discusses and characterizes of the interaction between the SARS-CoV-2 Nucleocapsid (N) protein and human chemokines.

Access the Application Note
A compendium for successful BLI and SPR assays
Application Guide

A Compendium for Successful BLI and SPR Assays

Octet® Label-Free Biosensor Analysis

Access the Guide
app note cover
Application Note

Mannose Glycans Content Screening for Human-mAb Samples

A novel approach for relative mannose content screening and ranking of human monoclonal antibody (mAb) samples using the Octet® GlyM Kit

Access Application Note

Comparability Studies: Minimize Time, Maintain Quality

Developing Methods for Comparability Studies of Therapeutic Monoclonal Antibodies

Access Webinar

Reduce Cycle Times for AAV Quantification

See the Octet AAVX Biosensor in comparison to an in-house assay on the Octet BLI platform.

Access Webinar

Download Now

datasheet cover

Octet® Residual Protein A Detection Kit

PDF | 386.7 KB
Octet® Systems in Bioprocessing: Easy-to-Use and Cost-Effective Tools for Multiple Applications
Application Guide

Octet® Systems in Bioprocessing: Easy-to-Use and Cost-Effective Tools for Multiple Applications

PDF | 282.5 KB
Octet® SF3 SPR

Octet® SF3 SPR 

Generate high-quality kinetics and affinity data in a fraction of the time compared to standard multi-cycle kinetics using the Octet® SF3.

Explore Octet® SF3
Octet® BLI rapidly determines recombinant protein concentration as a control parameter in cell line development.

96-Channel Ultra High Throughput Octet System: Octet® RH96

Monitors up to 96 biosensors simultaneously, enabling label-free detection for protein quantitation and kinetic characterization at unmatched speed

Explore Octet® RH96
Octet RH16 ultra high throughput label free detection system

16-Channel High Throughput Octet System: Octet® RH16

Ideal for high-throughput applications that demand high sensitivity and low sample volume requirements

Explore Octet® RH16
Octet R8 label free detection system instrument

8-Channel System: Octet® R8

Unmatched Flexibility and Versatility in Protein Analysis

Explore Octet® R8

Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Request a Quote, Demo, or More Information

Related Content


Biologics Characterization Tools

Explore More

Octet® System Service and Support

Explore More

Octet® BLI Resources

Explore More